share_log

Baird Maintains Outperform on Twist Bioscience, Raises Price Target to $46

Benzinga ·  Aug 5 19:14  · Ratings

Baird analyst Catherine Ramsey maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and raises the price target from $40 to $46.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment